Related Experiment Video
Updated: Jun 3, 2025
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
11.4K
Fibrinogen Structural Changes and Their Potential Role in Endometriosis-Related Thrombosis
Eleonora Fini1, Flavia Rita Argento1, Serena Borghi1
1Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Firenze, 50134 Firenze, Italy.
Antioxidants (Basel, Switzerland)
|January 8, 2025
Summary
Endometriosis patients show increased oxidative stress, altering fibrinogen structure and function. These changes promote a pro-thrombotic state, potentially increasing thrombosis risk in women with endometriosis.
Area of Science:
- Biochemistry
- Hematology
- Reproductive Medicine
Background:
- Endometriosis (EM) is a chronic inflammatory condition linked to higher thrombosis risk.
- The molecular mechanisms underlying this increased thrombotic risk in EM are not fully understood.
Purpose of the Study:
- To investigate structural and functional changes in fibrinogen in women with endometriosis.
- To explore the role of oxidative stress in these fibrinogen alterations and their association with thrombosis.
Main Methods:
- Case-control study comparing 71 EM patients and 71 controls.
- Measured oxidative stress markers (ROS, lipid peroxidation, antioxidant capacity).
- Analyzed fibrinogen structure (circular dichroism, fluorescence) and function (thrombin-induced polymerization, plasmin-induced lysis).
Main Results:
- EM patients exhibited elevated oxidative stress and ROS production compared to controls.
- Fibrinogen in EM patients showed oxidative modifications and structural changes.
- These alterations resulted in impaired fibrin polymerization and increased resistance to plasmin lysis, indicating a pro-thrombotic state.
Conclusions:
- Oxidative stress-induced fibrinogen modifications may contribute to the elevated thrombotic risk in women with endometriosis.
- Targeting these fibrinogen changes could be a therapeutic strategy to reduce cardiovascular complications in EM.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607
01:16Clot Retraction and Fibrinolysis
3.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.8K
01:17Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K
02:07Oogenesis
63.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.4K
01:22Hormonal Regulation of the Menstrual Cycle
283
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
283